Coya Therapeutics (COYA) Prepaid Assets (2021 - 2026)
Coya Therapeutics (COYA) posted Prepaid Assets of $1.8 million for Q1 2026, up 137.57% sequentially from $738157.0 in Q4 2025, and up 1118.25% YoY from $143949.0 in Q1 2025.
Coya Therapeutics (COYA) Prepaid Assets (2021 - 2026) Analysis & Trends
Coya Therapeutics has reported Prepaid Assets for 6 years, with the latest figure at $1.8 million in Q1 2026.
- Quarterly Prepaid Assets rose 1118.25% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 1118.25% YoY) and the FY2025 annual result came in at $738157.0, down 81.57% from the prior year.
- Prepaid Assets improved to $1.8 million in Q1 2026 per COYA's latest filing, from $738157.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $4.4 million in Q3 2024 and troughed at $24075.0 in Q4 2022.
- A 5-year average of $1.5 million and a median of $974161.5 in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets jumped 4556.4% in 2024, then tumbled 95.67% in 2025.
- Over 5 years, Prepaid Assets stood at $24075.0 in 2022, then soared by 257.28% to $86016.0 in 2023, then surged by 4556.4% to $4.0 million in 2024, then slumped by 81.57% to $738157.0 in 2025, then soared by 137.57% to $1.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.8 million, $738157.0, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Coya Therapeutics | 113.53 Mn | 70.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.88 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 738,157.00 |
| Sep 30, 2025 | 3.89 Mn |
| Jun 30, 2025 | 119,822.00 |
| Mar 31, 2025 | 143,949.00 |
| Dec 31, 2024 | 4.01 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 148,788.00 |
| Dec 31, 2023 | 86,016.00 |
| Sep 30, 2023 | 936,354.00 |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 24,075.00 |
| Dec 31, 2021 | 34,047.00 |